Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Quaid, M. Morris (1993)
Reluctance to undergo predictive testing: the case of Huntington disease.American journal of medical genetics, 45 1
Mary King, S. Rowell, S. Love (1993)
Inherited breast and ovarian cancer. What are the risks? What are the choices?JAMA, 269 15
W. Creasman, P. Disaia (1991)
Screening in ovarian cancer.American journal of obstetrics and gynecology, 165 1
Seymour Kessler, Tracy Field, Laura Worth, Heidi Mosbarger, J. Opitz, J. Reynolds (1987)
Attitudes of persons at risk for Huntington disease toward predictive testing.American journal of medical genetics, 26 2
Henry Lynch, W. Albano, John Heieck, Gabriel Mulcahy, J. Lynch, M. Layton, B. Danes (1984)
Genetics, biomarkers, and control of breast cancer: a review.Cancer genetics and cytogenetics, 13 1
C. Lerman, M. Daly, A. Masny, A. Balshem (1994)
Attitudes about genetic testing for breast-ovarian cancer susceptibility.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 12 4
M. Gail, L. Brinton, D. Byar, D. Corle, S. Green, C. Schairer, J. Mulvihill (1989)
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.Journal of the National Cancer Institute, 81 24
A. Tibben, H. Duivenvoorden, M. Vlis, M. Niermeijer, P. Frets, J. Kamp, R. Roos, H. Rooijmans, F. Verhage (1993)
Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention.American journal of medical genetics, 48 3
Carol Mastromauro, Carol Mastromauro, Richard Myers, Richard Myers, Barbara Berkman, J. Opitz, J. Reynolds (1987)
Attitudes toward presymptomatic testing in Huntington disease.American journal of medical genetics, 26 2
A. Tibben, P. Frets, J. Kamp, M. Niermeijer, Maria Vlis, R. Roos, H. Rooymans, G. Ommen, F. Verhage (1993)
On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program.American journal of medical genetics, 48 2
S. Wiggins, P. Whyte, M. Huggins, S. Adam, J. Theilmann, M. Bloch, S. Sheps, M. Schechter, M. Hayden (1992)
The Psychological Consequences of Predictive Testing for Huntington’s DiseaseThe New England Journal of Medicine, 327
D. Craufurd, L. Kerzin-Storrar, A. Dodge, Rodney Harris (1989)
UPTAKE OF PRESYMPTOMATIC PREDICTIVE TESTING FOR HUNTINGTON'S DISEASEThe Lancet, 334
G. Evers‐Kiebooms, A. Swerts, J. Cassiman, H. Berghe (1989)
The motivation of at‐risk individuals and their partners in deciding for or against predictive testing for Huntington's diseaseClinical Genetics, 35
R. Lam, M. Bloch, Jones Bd, Marcus Am, S. Fox, W. Amman, M. Hayden (1988)
Psychiatric morbidity associated with early clinical diagnosis of Huntington disease in a predictive testing program.The Journal of clinical psychiatry, 49 11
R. Croyle, C. Lerman (1993)
Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates.Preventive medicine, 22 2
M. Skolnick, L. Cannon-Albright (1992)
Genetic predisposition to breast cancerCancer, 70
J. Benichou (1993)
A computer program for estimating individualized probabilities of breast cancer.Computers and biomedical research, an international journal, 26 4
C. Lerman, R. Croyle (1994)
Psychological Issues in Genetic Testing for Breast Cancer SusceptibilityJAMA Internal Medicine, 154
Y. Miki, J. Swensen, D. Shattuck-Eidens, P. Futreal, K. Harshman, S. Tavtigian, Qingyun Liu, C. Cochran, L. Bennett, W. Ding, R. Bell, J. Rosenthal, C. Hussey, Thanh Tran, M. Mcclure, C. Frye, T. Hattier, R. Phelps, A. Haugen-Strano, H. Katcher, Kazuko Yakumo, Z. Gholami, Daniel Shaffer, S. Stone, Steven Bayer, Christian Wray, R. Bogden, P. Dayananth, J. Ward, P. Tonin, S. Narod, Pamela Bristow, F. Norris, L. Helvering, P. Morrison, P. Rosteck, Mei Lai, J. Barrett, C. Lewis, S. Neuhausen, L. Cannon-Albright, D. Goldgar, R. Wiseman, A. Kamb, M. Skolnick (1994)
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.Science, 266 5182
C. Lerman, M. Daly, C. Sands, A. Balshem, E. Lustbader, T. Heggan, L. Goldstein, J. James, P. Engstrom (1993)
Mammography adherence and psychological distress among women at risk for breast cancer.Journal of the National Cancer Institute, 85 13
M. Stefanek (1992)
Psychosocial aspects of breast cancerCurrent Opinion in Oncology, 4
Jeff Hall, Ming Lee, B. Newman, Jan Morrow, L. Anderson, B. Huey, M. King (1990)
Linkage of early-onset familial breast cancer to chromosome 17q21.Science, 250 4988
C. Lerman, B. Rimer, B. Trock, A. Balshem, P. Engstrom (1990)
Factors associated with repeat adherence to breast cancer screening.Preventive medicine, 19 3
Henry Lynch, P. Watson, T. Conway, J. Lynch, Sue Slominski‐Caster, S. Narod, Jean Feunteun, Gilbert Lenoir (1993)
DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.Archives of internal medicine, 153 17
Jeff Hall, L. Friedman, C. Guenther, Ming Lee, J. Weber, D. Black, M. King (1992)
Closing in on a breast cancer gene on chromosome 17q.American journal of human genetics, 50 6
M. Sheridan (1975)
Letter: The handicapped family.The Lancet, 2
M. Bloch, M. Fahy, S. Fox, M. Hayden, J. Reynolds (1989)
Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates.American journal of medical genetics, 32 2
R. Behrens, P. Phillips-Howard (1989)
WHAT DO TRAVELLERS KNOW ABOUT MALARIA?The Lancet, 334
D. Easton, D. Bishop, D. Ford, G. Crockford (1993)
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.American journal of human genetics, 52 4
E. Claus, N. Risch, W. Thompson (1991)
Genetic analysis of breast cancer in the cancer and steroid hormone study.American journal of human genetics, 48 2
K. Zerres, M. Stephan (1986)
ATTITUDES TO EARLY DIAGNOSIS OF POLYCYSTIC KIDNEY DISEASEThe Lancet, 328
M. Horowitz, N. Wilner, W. Alvarez (1979)
Impact of Event Scale: A Measure of Subjective StressPsychosomatic Medicine, 41
(1984)
Genetic testing in Huntington's diseaseAnnals of Neurology, 16
R. Sattin, G. Rubin, L. Webster, C. Huezo, P. Wingo, H. Ory, P. Layde (1985)
Family history and the risk of breast cancer.JAMA, 253 13
B. Biesecker, M. Boehnke, K. Calzone, D. Markel, J. Garber, F. Collins, F. Collins, B. Weber (1993)
Genetic counseling for families with inherited susceptibility to breast and ovarian cancer.JAMA, 269 15
C. McHorney, J. Ware, W. Rogers, Anastasia Raczek, J. Lu (1992)
The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study.Medical care, 30 5 Suppl
K. Kash, J. Holland, M. Halper, Daniel Miller (1992)
Psychological distress and surveillance behaviors of women with a family history of breast cancer.Journal of the National Cancer Institute, 84 1
(1993)
Cancer Facts and Figures —1993
C. Lerman, E. Lustbader, B. Rimer, M. Daly, S. Miller, C. Sands, A. Balshem (1995)
Effects of individualized breast cancer risk counseling: a randomized trial.Journal of the National Cancer Institute, 87 4
D. Markel, Anne Young, J. Penney (1987)
At-risk persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan.American journal of medical genetics, 26 2
R. Wooster, S. Neuhausen, J. Mangion, Y. Quirk, D. Ford, N. Collins, K. Nguyen, S. Seal, T. Tran, D. Averill (1994)
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.Science, 265 5181
J. Hornsby, J. Sappington, P. Mongan, W. Gullen, S. Bono, E. Altekruse (1985)
Risk for bladder cancer. Psychological impact of notification.JAMA, 253 13
The recent cloning of a breast‐ovarian cancer susceptibility gene (BRCA1), and determination of the locus of a related gene (BRCA2), offers potential for clinical genetic testing for breast cancer susceptibility. This study examined interest in and expectations about an impending genetic test among first‐degree relatives (FDRs) of breast cancer patients. One hundred five females completed two structured telephone interviews to assess demographics, breast cancer risk factors, psychological factors, and attitudes about genetic testing for breast cancer susceptibility. Overall, 91% of FDRs said that they would want to be tested, 4% said they would not, and 5% were uncertain. The most commonly cited reasons for wanting genetic testing were to learn about one's children's risk, to increase use of cancer screening tests, and to take better care of oneself. Women with less formal education were motivated by childbearing decisions and future planning to a greater degree than were women with education beyond high school. Most women anticipated a negative psychological impact of positive test results, involving increased anxiety (83%), depression (80%), and impaired quality of life (46%). In addition, 72% of women indicated that they would still worry if they tested negative. In multivariate regression analysis, level of baseline depression was the strongest predictor of an anticipated negative impact of genetic testing (Beta =.15; P,.0001). These results suggest that the demand for genetic testing for breast cancer susceptibility may be great, even among women who are not likely to have predisposing mutations. Prior to widespread availability of such testing, it will be critical to develop informed consent protocols to educate individuals about the benefits and limitations of predictive testing for this multifactorial disease. © 1995 Wiley‐Liss, Inc.
American Journal of Medical Genetics Part A – Wiley
Published: Mar 3, 1995
Keywords: ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.